Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BD Biosciences to Expand Manufacturing in Durham, North Carolina

Published: Monday, May 14, 2007
Last Updated: Monday, May 14, 2007
Bookmark and Share
The expansion of Treyburn facility will consolidate and increase U.S. manufacturing for BD Biosciences’ Discovery Labware product line.

BD Biosciences, a segment of BD (Becton, Dickinson and Company), has announced plans to expand its Treyburn facility in Durham, North Carolina to consolidate and increase U.S. manufacturing capacity for its Discovery Labware products, including BD Falcon™ products.

The $25 million capital investment project is expected to create 28 new positions in 2007 and a total of 100 by the end of 2008, building on a presence of approximately 285 employees today.

With expertise in fluid handling, tissue culture, and cell screening, BD Biosciences - Discovery Labware provides products and services with applications for drug discovery, high throughput screening, angiogenesis and tumor invasion.

The new capacity is intended to meet growing demand for BD Falcon™ tubes, pipettes, plates, cell inserts, and other products used in life science research settings. Approximately 50,000 square feet of manufacturing space will be added, directly contiguous to existing production lines.

“Treyburn offers an ideal platform as BD looks to increase capacity to meet demand for our Discovery Labware products,” said Todd Shackett, Plant Manager of the Treyburn facility. “We are able to build upon our own successful manufacturing operations, as well as the pool of high-tech expertise in this region. We couldn’t be more pleased to be growing in Durham. Today’s moves will provide the cornerstone for future development.”

Bill Kozy, Executive Vice President, added: “This expansion will allow BD to meet growing demand for class-leading products that are critical tools for life science researchers everywhere, while also enabling us to optimize our global production and supply chains for related products.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!